Alicia Dunajcik

Alicia Dunajcik

Auto-generated profile, based on publicly available information

Alicia Dunajcik

Centers for Disease Control and Prevention (CDC), COVID-19 Response Team, Atlanta, Georgia, United States of America

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
ADAlicia Dunajcik
Alicia Dunajcik
KHKambria Haire
Kambria Haire
JTJennifer D Thomas
Jennifer D Thomas
LMLeah F Moriarty
Leah F Moriarty
YSYuri Springer
Yuri Springer
MAMark Anderson
Mark Anderson
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) lineages, were initially detected internationally. This investigation examined available travel history of coronavirus disease 2019 (COVID-19) cases reported in the U.S. in whom laboratory testing showed one of these initial VOCs. Travel history, demographics, and health outcomes for a convenience sample of persons infected with a SARS-CoV-2 VOC from December 15, 2020 through February 28, 2021 were provided by 35 state and city health departments, and proportion reporting travel was calculated. Of 1,761 confirmed VOC cases analyzed, 1,368 had available data on travel history. Of those with data on travel history, 1,168 (85%) reported no travel preceding laboratory confirmation of SARS-CoV-2 and only 105 (8%) reported international travel during the 30 days preceding a positive SARS-CoV-2 test or symptom onset. International travel was reported by 92/1,304 (7%) of persons infected with the Alpha variant, 7/55 (22%) with Beta, and 5/9 (56%) with Gamma. Of the first three SARS-CoV-2 lineages designated as VOCs in the U.S., international travel was common only among the few Gamma cases. Most persons infected with Alpha and Beta variant reported no travel history, therefore, community transmission of these VOCs was likely common in the U.S. by March 2021. These findings underscore the importance of global surveillance using whole genome sequencing to detect and inform mitigation strategies for emerging SARS-CoV-2 VOCs.

17 November 2026 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
ADAlicia Dunajcik
Alicia Dunajcik
EMEmily R. McDonald
Emily R. McDonald
ASApril D. Summers
April D. Summers
AEAmy Esler
Amy Esler
MGMaria G. Gonzalez
Maria G. Gonzalez
STSarah C. Tinker
Sarah C. Tinker